Back to results
US 2012/0252089 A1Published application
Cytocompatible alginate gels
AssigneeAbbott Cardiovascular Systems Inc.
InventorsShubhayu Basu, Gene Michal, Florian Ludwig, Jingping Wan, John Stankus
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.
Claims13
A method of forming a cytocompatible alginate gel, comprising:
- providing an alginate;
- dispersing substantially homogeneously within the alginate a plurality of cells;
- dispersing substantially homogeneously within the alginate a plurality of nano or microparticles, wherein:
- the microparticles comprise an alginate lyase;
- and
- a divalent metal cation to form an alginate gel.
3 more elements
A method of forming a cytocompatible alginate gel, comprising:
- providing an alginate;
- dispersing substantially homogeneously within the alginate a plurality of cells;
- dispersing substantially homogeneously within the alginate an alginate lyase;
- and
- adding to the alginate a divalent metal cation to form an alginate gel.
2 more elements
A method of forming a cytocompatible alginate gel, comprising:
- providing an alginate;
- dispersing substantially homogeneously within the alginate a plurality of cells;
- dispersing substantially homogeneously within the alginate a PEGylated alginate lyase within a degradable microsphere;
- and
- adding to the alginate a divalent metal cation to form an alginate gel.
2 more elements
Dependencies are inferred from the claim text.